Hormone Therapy and Castration Resistance of Prostate Cancer
Arai, Y.; Ogawa, O.
Canadian Journal of Urology 26(2): 9686
2019
ISSN/ISBN: 1195-9479 PMID: 31012829 Document Number: 698298
Document emailed within 1 workday
Related Documents
Miyake, H.; Fujisawa, M. 2014: Antisense oligodeoxynucleotide therapy for castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2121-2125Hu, Y.-H.; Guo, J.-C.; Zhang, M. 2017: Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(12): 1138-1140
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M. 2010: New perspectives in the drug therapy of hormone-resistant prostate cancer Voprosy Onkologii 56(6): 645-653
Nicol, D.L.; Heathcote, P.S.; Kateley, G.D.; Lloyd, S. 1993: Advanced prostate cancer. the role of high priced hormone therapy Medical Journal of Australia 159(1): 16-19
Rosino, A.; Ballester, I.; Tudela, J.án.; González-Billalabeitia, E. 2018: Chemotherapy in metastatic castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 676-684
Vázquez-Alonso, F.; Puche-Sanz, I.; Cózar-Olmo, J.é M. 2018: Recommendations for follow up in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 735-742
Naito, S.; Shiota, M. 2014: The concept and mechanisms of castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2090-2094
Alvarez Rodríguez, S.; Alonso Gordoa, T.; Burgos Revilla, F.Javier. 2018: Current status of androgen deprivation therapy in hormone-sensitive prostate cancer Archivos Espanoles de Urologia 71(3): 247-257
Ying, J.; Yao, D.-H.; Ren, X.-M. 2003: Study of sexual hormone changes in prostate cancer patients before and after androgen deprivation therapy Zhonghua Nan Ke Xue 9(3): 191-192; 196
Gomella, L.G.; Petrylak, D.P.; Shayegan, B. 2014: Current management of advanced and castration resistant prostate cancer Canadian Journal of Urology 21(2 Supp 1): 1-6
Ojeda, A.V.; Ledo, M.ía.J.é; Alvarez-Ossorio, J.é L.ís. 2018: Sequencing and combination of agents in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 711-720
Gumenetskaya, Y.V.; Mardynsky, Y.S.; Karyakin, O.B.; Gulidov, I.A.; Biryukov, V.A. 2015: An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer Voprosy Onkologii 61(1): 57-61
Bishr, M.; Lattouf, J.B.; Gannon, P.O.; Saad, F. 2011: Updates on therapeutic targets and agents in castration-resistant prostate cancer Minerva Urologica e Nefrologica 63(2): 131-143
Maeno, A.; Habuchi, T. 2016: Current status of castration-resistant prostate cancer translational research Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 40-44
Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124
St-Arnaud, R.; Lachance, R.; Dupont, A.; Labrie, F. 1986: Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 9(4): 215-221
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Wang, W.; Peng, R.-x.; Shi, G.-w.; Chen, S.-y.; Ding, Q.; He, J.-y. 2015: Treatment of castration-resistant prostate cancer: Evidence-based clinical practice Zhonghua Nan Ke Xue 21(12): 1121-1124